The Japanese legal cannabinoid market may soon have yet another acronym to learn. If you’ve only just wrapped your head around THAH and CBX, I have some good news (or bad news, depending on how you feel about four-letter abbreviations): THCF may be next.
Who Announced It?
BudsBrain has announced that it expects to receive a sample of a new cannabinoid raw material called THCF from the Czech Republic on July 21, 2026.
But that doesn’t mean we’ll be smoking it anytime soon. At the time of writing, no consumer products containing THCF have been released, and no Certificate of Analysis (COA) has been published. According to BudsBrain, the plan is to:
- Receive the sample
- Conduct internal tasting and evaluation
- Obtain a final COA
- Share both the COA and testing results publicly before releasing any products
In the same announcement, BudsBrain reaffirmed its commitment to transparency, saying it will continue using real cannabinoid names rather than vague marketing terms, even if that helps competitors identify the same raw materials or attracts future regulatory scrutiny.
Read more: How to Read a COA in Japan (Decoding Certificates of Analysis for Cannabinoid Products)
What Does the Manufacturer Say?
Although BudsBrain has not yet released any technical information about THCF, a Czech cannabinoid manufacturer has published a more detailed description of the compound.
According to the manufacturer, THCF (Tetrahydromethylisopentyl-ethylcannabinol) is marketed as a sativa-selective cannabinoid designed to provide a clear, functional, and euphoric experience, rather than the heavier, more sedating effects often associated with cannabinoids such as Delta-9 THC, THCP, and HHC.
The manufacturer also claims THCF may offer:
- A reported onset of 10–30 minutes after inhalation.
- A duration of approximately 3–4 hours.
- A lower likelihood of anxiety or paranoia.
- More stable effects with repeated use.
- Increased synergy when combined with other cannabinoids.
Those are certainly interesting claims—especially given the growing popularity of brighter, daytime-oriented cannabinoids in Japan.
Interestingly, another European company refers to the same compound as NL-1, suggesting THCF may also be marketed under an alternate trade name in parts of Europe.
THCF and NL-1: Are They the Same Thing?
One interesting discovery during my research (aka, pooling crucial intel on r/altnoidsjapan) is that other European manufacturers appear to use the names THCF and NL-1 interchangeably. At the time of writing, it’s not entirely clear whether NL-1 is a trade name, a marketing name, or another designation for the same cannabinoid, but both descriptions appear to refer to the same compound.
One challenge in researching THCF is that publicly available information remains limited, and different companies sometimes use inconsistent names or descriptions for what may be the same compound. Until independently verified analytical data becomes available, it’s difficult to confirm exactly how these various products relate to one another.
It’s also important to note that these claims appear to come from the manufacturer(s) itself. At the time of writing, I haven’t found any independent, peer-reviewed research confirming these properties, so it’s best to treat them as preliminary rather than established fact.
So… What Is THCF?
Right now, the honest answer is: We’re still learning.
At the moment there appear to be two competing narratives surrounding THCF. Manufacturers describe it as a novel functional cannabinoid with a sativa-like profile, while some experienced members of the European cannabinoid community have questioned whether products marketed under names such as THCF or NL-1 represent genuinely new cannabinoids or simply rebranded synthetic compounds.
I still haven’t found enough independent evidence to verify either position, which is why I’ll be paying close attention to any future COAs, analytical testing, and independent research as they become available.
Interestingly still, although published by different European companies, the descriptions of THCF are remarkably consistent. All companies I’ve seen so far portray it as a bright, functional, daytime-oriented cannabinoid with a more “sativa-like” profile than many existing alternatives. Those descriptions remain manufacturer claims rather than independently verified scientific findings, of course.
So for now, beyond BudsBrain’s announcement and the information published by the European sources I mentioned, very little is publicly known about THCF. There are currently no published COAs for the Japanese market, no commercial products available in Japan, and no independent research confirming many of the claims being made about its effects.
So rather than jumping to conclusions, I’ll be keeping an eye on the COA, future product releases, and any reliable evidence that emerges.
As more information becomes available—including analytical data, product launches, and real-world experiences—I’ll continue updating this page.
Final Thoughts
Right now, THCF remains one to watch…🍃
Leave a Reply